Cite
APA Citation
Taylor, P., Genovese, M. C., Keystone, E., Schlichting, D., Beattie, S., & Macias, W. (2013). oP0047 Baricitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Study. Annals of the rheumatic diseases, 72, A65–A66. http://access.bl.uk/ark:/81055/vdc_100137792226.0x00005d